LHI: Set, I.V. Fluid Transfer
What it covers
An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.
The identification in 21 CFR 880.5440, intravascular administration set. FDA gives LHI no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K252987 | ADRx Admixture Device | Epic Medical Pte. , Ltd. | Jun 12, 2026 | Traditional |
| K260301 | Vial Adapter | Hangzhou Qiantang Longyue Biotechnology Co., Ltd. | Jun 5, 2026 | Traditional |
| K250345 | Medline Bag Decanter | Medline Industries, LP | Oct 24, 2025 | Traditional |
| K251715 | FlowArt® Vial Access Device Vented | Asset Medikal | Oct 14, 2025 | Traditional |
| K251676 | Medline Microtek C-Flo Bag Decanter, Sterile (2000S); Medline Microtek Bag Decanter II, Sterile (2002S); Medline Microtek Vial Decanter, Sterile (2006S); Medline Microtek Transfer Device, Sterile (2008S) | Microtek Medical, LLC | Sep 16, 2025 | Traditional |
| K243404 | HyHub and HyHub Duo Vial Access Devices | Takeda Pharmaceuticals | Jul 18, 2025 | Traditional |
| K240761 | Arisure® Closed Male Luer with Spike Adapter (YM060) | Yukon Medical, LLC | Mar 21, 2025 | Traditional |
| K243985 | Rio Drug Reconstitution Transfer Device | Icu Medical, Inc. | Jan 22, 2025 | Traditional |
| K243486 | SmartSiteTM Vented Vial Access Device | Yukon Medical, LLC | Dec 6, 2024 | Traditional |
| K241976 | nextaro® va, 15mm, 5µm | Sfm Medical Devices GmbH | Sep 6, 2024 | Special |
Clearances by year
67 LHI 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 2 | 197 |
| 2025 | 6 | 196 |
| 2024 | 9 | 166 |
| 2023 | 5 | 90 |
| 2022 | 5 | 300 |
| 2021 | 3 | 396 |
| 2020 | 3 | 189 |
| 2019 | 4 | 247 |
| 2018 | 1 | 199 |
| 2017 | 5 | 56 |
| 2016 | 3 | 159 |
| 2015 | 3 | 99 |
| 2014 | 6 | 63 |
| 2013 | 4 | 102 |
| 2012 | 5 | 127 |
| 2011 | 3 | 99 |
Who submits
41 applicants cleared a LHI device since 2011. 48% of the clearances went to applicants in United States, then Israel (16%), China (10%) and Germany (6%). By type: Traditional 82%, Special 15% and Abbreviated 3%. 10 went through a third-party review organization.
| Applicant | Clearances since 2011 |
|---|---|
| Yukon Medical, LLC | 6 |
| West Pharma. Services IL, Ltd. | 5 |
| B.Braun Medical, Inc. | 4 |
| Hangzhou Qiantang Longyue Biotechnology Co., Ltd. | 4 |
| Medimop Medical Projects, Ltd. | 4 |
| Medsource International, LLC | 3 |
| Sfm Medical Devices GmbH | 3 |
| Avenir Performance Europeenne Medical (Apem) | 2 |
How FDA classifies it
Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.
From 21 CFR 880.5440. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 880.5440 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent LHI clearances declared.
Ask about LHI
Questions about LHI
What is FDA product code LHI?
Product code LHI, “Set, I.V. Fluid Transfer” in FDA's classification database, is a Class II device type under 21 CFR 880.5440 (intravascular administration set), reviewed by FDA's General Hospital panel. FDA's 510(k) database lists 206 clearances under LHI, 67 of them since 2011.
How many 510(k) clearances are there under LHI?
FDA’s 510(k) database listed 206 clearances under LHI as of Oct 29, 2026, 67 of them decided since 2011; the most recent decision was Jun 12, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a LHI 510(k)?
For the 9 LHI clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 132 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most LHI clearances?
Since 2011: Yukon Medical, LLC (6), West Pharma. Services IL, Ltd. (5), B.Braun Medical, Inc. (4), Hangzhou Qiantang Longyue Biotechnology Co., Ltd. (4) and Medimop Medical Projects, Ltd. (4). 41 applicants have cleared a LHI device in that time.